Adhesion polypeptides are useful for the prevention of peritoneal dissemination of gastric cancer.
We examined the effect of adhesion polypeptides on the adhesion and invasiveness of gastric cancer cell lines. We previously reported the establishment of an extensively peritoneal-seeding cell line, OCUM-2MD3, from a poorly seeding human scirrhous gastric carcinoma cell line, OCUM-2M. Both alpha2beta1 and alpha3beta1 integrin expression was markedly increased on OCUM-2MD3 cells compared with OCUM-2M cells, and the ability of OCUM-2MD3 cells to bind to the extracellular matrix (ECM) was also significantly higher than that of OCUM-2M cells. The adhesion polypeptides, YIGSR and RGD, and two RGD derivatives significantly inhibited the adhesion of OCUM-2MD3 cells to the submesothelial ECM, while not inhibiting the adhesiveness of OCUM-2M cells and two well differentiated human gastric cell lines, MKN-28 and MKN-74. The YIGSR and RGD peptides also significantly inhibited the invasiveness of OCUM-2MD3 cells. The survival of nude mice with peritoneal dissemination given YIGSR sequence intraperitoneally was obviously longer than that of untreated mice. The survival of mice treated with RGD was also improved, and this effect was increased using the RGD derivatives, poly(CEMA-RGDS) and CM-chitin RGDS. These polypeptides appear to block the binding of integrins, which are expressed on OCUM-2MD3 cells, to the submesothelial ECM, and consequently inhibit peritoneal implantation. The peritoneal injection of adhesion polypeptides may be a new therapy against the dissemination of scirrhous gastric cancer, and may be useful for the prevention of dissemination in high-risk patients.
Matsuoka
T
T
First Department of Surgery, Osaka City University Medical School, Osaka, Japan.
Hirakawa
K
K
Chung
Y S
YS
Yashiro
M
M
Nishimura
S
S
Sawada
T
T
Saiki
I
I
Sowa
M
M
D002293:Adenocarcinoma, Scirrhous / Q000473:pathology / Q000517:prevention & control / Q000556:secondary; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D006801:Humans; D051379:Mice; D008819:Mice, Nude; D009361:Neoplasm Invasiveness; D009842:Oligopeptides / Q000494:pharmacology; D010455:Peptides / Q000494:pharmacology*; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000517:prevention & control* / Q000556:secondary*; D013274:Stomach Neoplasms / Q000473:pathology / Q000517:prevention & control*; D014407:Tumor Cells, Cultured
D009842:Oligopeptides; D010455:Peptides; C081571:tyrosyl-isoleucyl-glycyl-seryl-arginine; C060414:acetyl-arginyl-glycyl-aspartyl-serinamide; C047981:arginyl-glycyl-aspartic acid